EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules

Reema Anaam iD, Israa H Isawi iD, Qosay Al-Balas iD

Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-23

DOI: 10.2147/dddt.s575242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Reema Anaam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Lactoylglutathione Lyase, Water, Enzyme Inhibitors, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glyoxalase-I (GLO-I) is a zinc-dependent metalloenzyme and a promising target for anticancer drug discovery. It catalyzes the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis, a metabolic shift commonly observed in cancer cells. GLO-I overexpression in tumor cells promotes multidrug resistance and tumor progression. However, the role of conserved water molecules within the GLO-I active site remains insufficiently explored, and understanding their influence on ligand binding may improve structure-based inhibitor design.

Purpose

This study aimed to identify potential GLO-I inhibitors by examining the effect of conserved active site water molecules on ligand binding and activity predictions using a structure-based drug design approach. Materials and Methods: Three human GLO-I crystal structures were used to generate structure-based pharmacophore models under two conditions: with and without crystallographic active site water molecules. The models were applied to virtually screen the OTAVA Lead-Like library (commercial lead-like compound library). Molecular docking of the resulting hits was then performed under both hydration conditions to evaluate effects on ligand binding affinity and pose orientation. Top-ranked compounds were purchased and evaluated in vitro for GLO-I inhibition. The most active hit was further evaluated by 1000 ns molecular dynamics (MD) simulations (± crystallographic waters), including analysis of pose stability and binding-site water behavior. Results: of 12.07 ± 0.31 μM and 85.63% inhibition at 50 μM. Docking analysis indicated that including crystallographic water molecules often increased docking scores but could distort binding orientations, whereas docking without conserved active site water molecules more consistently produced plausible poses and better agreement with experimental activity trends.

Conclusion

For GLO-I, docking without conserved active site water molecules provided more accurate results and may represent a more reliable approach for studying ligand binding and guiding inhibitor design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactoylglutathione LyaseWaterEnzyme InhibitorsDrug DiscoveryHumansMolecular Docking SimulationCatalytic DomainStructure-Activity RelationshipMolecular StructurePharmacophoreLigandsDose-Response Relationship, Drug

Stichwörter der Autor:innen

anticancercrystallographic water effectglyoxalase-Imolecular dockingpharmacophore modeling

Substanzen

Lactoylglutathione LyaseWaterEnzyme InhibitorsGLO1 protein, humanLigands

Autor:innen und Institutionen

  • Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

ORCID-Profile: Reema Anaam, Israa H Isawi, Qosay Al-Balas

Zitieren

APA

Anaam, R., Isawi, I. H., & Al-Balas, Q. (2026). Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules. Drug Design, Development and Therapy, Volume 20, 1-23. https://doi.org/10.2147/dddt.s575242

Vancouver

Anaam R, Isawi IH, Al-Balas Q. Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules. Drug Design, Development and Therapy. 2026;Volume 20:1-23. doi:10.2147/dddt.s575242

BibTeX
@article{Anaam2026,
  author = {Anaam, Reema and Isawi, Israa H and Al-Balas, Qosay},
  title = {Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--23},
  doi = {10.2147/dddt.s575242}
}
Kostenlos starten →